Molecular Mechanisms of iNOS Degradation

iNOS 降解的分子机制

基本信息

  • 批准号:
    6670791
  • 负责人:
  • 金额:
    $ 10.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-07-01 至 2008-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The candidate is a recently independent physician-scientist who has shown strong commitment to biomedical research. His long-term career goal is to develop a strong research program in molecular mechanisms of airway inflammation. His immediate research goals are to understand the molecular mechanisms of regulation NO synthesis by inducible nitric oxide synthase (iNOS) in airway cells and devise methods to control it. A successful R01 application has the candidate poised to continue his current studies, initiate new programs, acquire new skills and build new collaborations. The K02 award is needed to reduce the clinical component of the candidate's current appointment, thus allowing a period of intensive research focus to foster his scientific development and expand his potential to make significant research contributions. The candidate is in a highly supportive environment with excellent mentors and numerous opportunities for intellectual development. He is a faculty member of a newly established center for "Biology of Inflammation". The candidate's laboratory is within the center and its core laboratories, which comprise 20,000 sq, ft. of newly renovated state-of-the-art-open lab design facilities. The center's research environment offers a dynamic critical mass of investigators providing a synergistic environment for the candidate's research. The overall objective of the core research project (a five-year R01 funded 8/1/02) is to understand the mechanisms of iNOS degradation in airway epithelial cells. It consists of four specific aims: 1) Identification of human iNOS degradation pathway. 2) Characterization of possible role of ubiquitination in iNOS degradation. 3) Elucidation of the subcellular localization of human iNOS. 4) Analysis of modulation of iNOS degradation by allosteric inhibitors. The candidate is addressing three additional specific aims through collaborative studies: I) Determination of specific sites of iNOS ubiquitination. II) Elucidation of Role of phosphorylation in iNOS ubiquitination. III) Identification of specific ubiquitin ligase (E3) responsible for iNOS ubiquitination. Studies will be conducted in epithelial cell lines and in primary airway bronchial epithelial cells. The rational for the proposed studies is that once the degradation mechanisms of iNOS are understood, therapeutic strategies can be designed to alter these pathways and modulate iNOS degradation. The results of these studies will increase our understanding of the cellular process of iNOS regulation and thus lay the groundwork for future studies aiming at controlling NO synthesis in diseases of airway inflammation such as asthma.
描述(由申请人提供):候选人是一个最近独立的医生,科学家谁表现出强烈的承诺,生物医学研究。他的长期职业目标是在气道炎症的分子机制方面发展强大的研究计划。他的近期研究目标是了解气道细胞中诱导型一氧化氮合酶(iNOS)调节NO合成的分子机制,并设计控制方法。成功的R 01申请使候选人准备继续他目前的研究,启动新的项目,获得新的技能和建立新的合作。K 02奖需要减少候选人目前任命的临床部分,从而允许一段时间的密集研究重点,以促进他的科学发展,并扩大他做出重大研究贡献的潜力。 候选人处于一个高度支持的环境中,拥有优秀的导师和众多的智力发展机会。他是新成立的“炎症生物学”中心的教员。候选人的实验室位于中心及其核心实验室内,其中包括20,000平方英尺。新装修的最先进的开放式实验室设计设施。该中心的研究环境提供了一个动态的临界质量的研究人员提供了一个协同的环境,为候选人的研究。 核心研究项目的总体目标(一个为期五年的R 01资助8/1/02)是了解气道上皮细胞中iNOS降解的机制。本研究的主要目的是:1)鉴定人iNOS的降解途径。2)泛素化在诱导型一氧化氮合酶降解中可能作用的表征。3)阐明人iNOS的亚细胞定位。4)通过别构抑制剂调节iNOS降解的分析。候选人通过合作研究解决了三个额外的具体目标:I)确定iNOS泛素化的特定位点。II)阐明磷酸化在iNOS泛素化中的作用。III)鉴定负责iNOS泛素化的特异性泛素连接酶(E3)。将在上皮细胞系和原代气道支气管上皮细胞中进行研究。 提出的研究的理由是,一旦了解了iNOS的降解机制,就可以设计治疗策略来改变这些途径并调节iNOS的降解。这些研究的结果将增加我们对iNOS调节的细胞过程的理解,从而为未来旨在控制气道炎症疾病(如哮喘)中NO合成的研究奠定基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

N. Tony Eissa其他文献

Gene therapy for the respiratory manifestations of cystic fibrosis.
针对囊性纤维化呼吸道表现的基因治疗。

N. Tony Eissa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('N. Tony Eissa', 18)}}的其他基金

Therapeutic Strategy for LAM (Lymphangioleiomyomatosis)
LAM(淋巴管平滑肌瘤病)的治疗策略
  • 批准号:
    8768835
  • 财政年份:
    2013
  • 资助金额:
    $ 10.06万
  • 项目类别:
Therapeutic Strategy for LAM (Lymphangioleiomyomatosis)
LAM(淋巴管平滑肌瘤病)的治疗策略
  • 批准号:
    8599141
  • 财政年份:
    2013
  • 资助金额:
    $ 10.06万
  • 项目类别:
CYSTIC FIBROSIS MUTANT
囊性纤维化突变体
  • 批准号:
    8361139
  • 财政年份:
    2011
  • 资助金额:
    $ 10.06万
  • 项目类别:
Cellular Regulation of Nitric Oxide in Airway Inflammation
一氧化氮在气道炎症中的细胞调节
  • 批准号:
    7824705
  • 财政年份:
    2009
  • 资助金额:
    $ 10.06万
  • 项目类别:
Cellular Regulation of Nitric Oxide in Airway Inflammation
一氧化氮在气道炎症中的细胞调节
  • 批准号:
    7342121
  • 财政年份:
    2007
  • 资助金额:
    $ 10.06万
  • 项目类别:
Cellular Regulation of Nitric Oxide in Airway Inflammation
一氧化氮在气道炎症中的细胞调节
  • 批准号:
    7571586
  • 财政年份:
    2007
  • 资助金额:
    $ 10.06万
  • 项目类别:
Cellular Regulation of Nitric Oxide in Airway Inflammation
一氧化氮在气道炎症中的细胞调节
  • 批准号:
    7209918
  • 财政年份:
    2007
  • 资助金额:
    $ 10.06万
  • 项目类别:
Cellular Regulation of Nitric Oxide in Airway Inflammation
一氧化氮在气道炎症中的细胞调节
  • 批准号:
    7755017
  • 财政年份:
    2007
  • 资助金额:
    $ 10.06万
  • 项目类别:
iNOS Aggresome as a Prototype of a Physiologic Aggresome
iNOS Aggresome 作为生理 Aggresome 的原型
  • 批准号:
    7034438
  • 财政年份:
    2006
  • 资助金额:
    $ 10.06万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7150848
  • 财政年份:
    2006
  • 资助金额:
    $ 10.06万
  • 项目类别:

相似海外基金

Defining new asthma phenotypes using high-dimensional data
使用高维数据定义新的哮喘表型
  • 批准号:
    2901112
  • 财政年份:
    2024
  • 资助金额:
    $ 10.06万
  • 项目类别:
    Studentship
Basophilic oncostatin M fuels nociceptor neuron-induced asthma
嗜碱性制瘤素 M 促进伤害感受器神经元诱发哮喘
  • 批准号:
    485504
  • 财政年份:
    2023
  • 资助金额:
    $ 10.06万
  • 项目类别:
    Salary Programs
Engaging Patient and Caregivers in Using Patient-reported Outcomes Measures in Pediatric Clinical Care for Asthma
让患者和护理人员参与儿科哮喘儿科临床护理中患者报告的结果测量
  • 批准号:
    495593
  • 财政年份:
    2023
  • 资助金额:
    $ 10.06万
  • 项目类别:
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
  • 批准号:
    485322
  • 财政年份:
    2023
  • 资助金额:
    $ 10.06万
  • 项目类别:
    Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
  • 批准号:
    493135
  • 财政年份:
    2023
  • 资助金额:
    $ 10.06万
  • 项目类别:
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
  • 批准号:
    493526
  • 财政年份:
    2023
  • 资助金额:
    $ 10.06万
  • 项目类别:
    Operating Grants
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
  • 批准号:
    10659658
  • 财政年份:
    2023
  • 资助金额:
    $ 10.06万
  • 项目类别:
Treating Maternal Depression in an Urban Community-Based Pediatric Asthma Clinic: Targeting Maternal Mood, Child Asthma Outcomes, and Health Disparities
在城市社区小儿哮喘诊所治疗孕产妇抑郁症:针对孕产妇情绪、儿童哮喘结果和健康差异
  • 批准号:
    10723233
  • 财政年份:
    2023
  • 资助金额:
    $ 10.06万
  • 项目类别:
Improving Prediction of Asthma-related Outcomes with Genetic Ancestry-informed Lung Function Equations
利用遗传祖先信息的肺功能方程改善哮喘相关结果的预测
  • 批准号:
    10723861
  • 财政年份:
    2023
  • 资助金额:
    $ 10.06万
  • 项目类别:
Prenatal Fatty Acid Supplementation and Early Childhood Asthma and Atopy in Black American Families
美国黑人家庭产前脂肪酸补充剂与儿童早期哮喘和特应性
  • 批准号:
    10586398
  • 财政年份:
    2023
  • 资助金额:
    $ 10.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了